MR-guided percutaneous biopsy of solitary pulmonary lesions using a 1.0-T open high-field MRI scanner with respiratory gating

Liu, Ming; Huang, Jie; Xu, Yanjun; He, Xijing; Li, Lei; Lü, Yubo; Liu, Qiang; Sequeiros, Roberto Blanco; Li, Chengli

doi:10.1007/s00330-016-4518-9

Cited by 15 publications

(25 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The first MRI-guided clinical trials were reported in 1986 (13). Since then, MRI-guided clinical applications have been successfully applied to lesions in various anatomical regions, such as pancreatic, breast, prostate, lung tumor, and renal tumor lesions (14)(15)(16)(17)(18). After ∼20 years of clinical use, MRIguided breast biopsy has evolved into a routine method in Western European countries (19,20).…”

Section: Discussionmentioning

confidence: 99%

Clinical Application and Feasibility of MRI-Guided Breast Biopsy of Breast Minimal Lesions in Chinese Population

et al. 2020

View full text Add to dashboard Cite

Objectives: Some breast lesions are not visible on mammography or ultrasonography, and magnetic resonance imaging (MRI) become the only way to monitor these lesions. The purpose of this study was to evaluate the clinical application of MRI-guided biopsy and MRI-guided wire localization of breast minimal lesions in Chinese population. Methods:We evaluated 95 patients (the most patients of known in China) from August 2013 to December 2017. All the patients were scanned with a 1.5-Tesla MRI system (GE Medical Systems, America) in the prone position using a bilateral 8-channel phased-array breast coil and underwent MRI-guided wire localization or MRI-guided biopsy.Results: MRI-guided wire localization and MRI-guided biopsy were successfully performed in 87 patients with 88 lesions (100%, 88/88). After biopsy or surgery, 36 of 88 lesions (40.91%) were malignant, and 52 of 88 lesions (59.09%) were benign. Thirty-nine of 88 lesions (44.32%) were masses, and 49 of 88 (55.68%) showed non-mass enhancement. Statistical analysis showed there was no significant correlation between the malignancy rate and the type of lesion on MRI (P = 0.27). In this study, the rate of malignancy for Breast Imaging-Reporting and Data System (BI-RADS) 5 lesions was 100% (2 of 2) compared with 44.44% for BI-RADS 4C lesions (4 of 9), 42.42% for BI-RADS 4B lesions (14 of 33), and 36.36% for BI-RADS 4A lesions (16 of 44).Conclusions: MRI-guided wire localization with subsequent surgical biopsy and MRI-guided biopsy are safe and effective tools for breast minimal lesions.

show abstract

Section: Discussionmentioning

confidence: 99%

Clinical Application and Feasibility of MRI-Guided Breast Biopsy of Breast Minimal Lesions in Chinese Population

et al. 2020

View full text Add to dashboard Cite

show abstract

“…The needle entry point was determined by MRI with a matrix grid made of fish oil capsules, details of which have been reported elsewhere . The approach angle and distance (from the skin to the lesion) was measured.…”

Section: Methodsmentioning

confidence: 99%

“…Magnetic resonance imaging (MRI) offers many inherent advantages over CT and US in terms of superior soft‐tissue contrast resolution, blood flow‐empty action, a nonionizing nature, and direct multiplanar capabilities. MR guidance has been successfully implemented for percutaneous biopsy and various therapies . Thus, the purpose of this study was to prospectively evaluate the safety and accuracy of MRI‐guided percutaneous coaxial cutting needle biopsy of pancreatic lesions using an open 1.0T high‐field MR scanner.…”

mentioning

confidence: 99%

1.0T MR‐guided percutaneous coaxial cutting needle biopsy in pancreatic lesion diagnosis

Liu

Wang

et al. 2018

Magnetic Resonance Imaging

Self Cite

View full text Add to dashboard Cite

show abstract

“…Enhanced chest CT is recommended at 1, 3,6,9,12,18,24,30,36,42,48,54, and 60 months after implantation. After five years, a chest CT scan should be taken once a year.…”

Section: Follow-upmentioning

confidence: 99%

Chinese Expert Consensus Workshop Report: Guideline for permanent iodine‐125 seed implantation of primary and metastatic lung tumors

et al. 2018

View full text Add to dashboard Cite

Surgery remains the first choice of cure for early stage lung cancer. However, many patients are diagnosed at advanced stage, and thus miss the opportunity to undergo surgery. As such patients derive limited benefits from chemotherapy or radiotherapy, alternatives focusing on local control have emerged, including iodine‐125 seed implantation. The Interstitial Brachytherapy Society, Committee of Minimally Invasive Therapy in Oncology, Chinese Anti‐Cancer Association organized a group of multidisciplinary experts to develop guidelines for this treatment modality. These guidelines aim to standardize iodine‐125 seed implantation procedures, inclusion criteria, and outcome assessment to prevent and manage procedure‐related complications.

show abstract

MR-guided percutaneous biopsy of solitary pulmonary lesions using a 1.0-T open high-field MRI scanner with respiratory gating

Abstract: • MRI-guided percutaneous lung biopsy using a 1.0-T open MR scanner is feasibility. • 96.9 % differentiation accuracy of malignant and benign lung lesions is possible. • No serious complications occurred in MRI-guided lung biopsy.

Cited by 15 publications

References 28 publications

Clinical Application and Feasibility of MRI-Guided Breast Biopsy of Breast Minimal Lesions in Chinese Population

Clinical Application and Feasibility of MRI-Guided Breast Biopsy of Breast Minimal Lesions in Chinese Population

1.0T MR‐guided percutaneous coaxial cutting needle biopsy in pancreatic lesion diagnosis

Chinese Expert Consensus Workshop Report: Guideline for permanent iodine‐125 seed implantation of primary and metastatic lung tumors

Contact Info

Product

Resources

About